Share

    


Home / Search Results

Search Results

Search Again?

Filter By Topic

Pandemic Planning Clinical Guideline for Patients with Cancer March 10 2020 2 Pandemic Planning Clinical Guideline for Patients with Cancer Contents INTRODUCTION .................................................................................................. 4 Planning Assumptions …
Guidance for Cancer Programs Guidance for Cancer Programs During the Coronavirus Outbreak From Jennie R. Crews, MD, MMM, FACP Medical Director, Seattle Cancer Care Alliance Network; ACCC Past President • Take social distancing seriously. • Formulate your policies and procedures now on testing algorithms. • Establish testing locations such as drive-through screenings. • Screen …
ACCC collaborated with the American Cancer Society Cancer Action Network and 13 other stakeholder organizations in a collaborative letter responding to ClinicalTrials.gov's request for information to guide their modernization process. Read the Letter
“In this town, we’ve seen healthcare become a political lightning rod,” U.S. Senator Debbie Stabenow (D-MI) told attendees on March 5 at the ACCC 46th Annual Meeting & Cancer Center Business Summit (AMCCBS) in Washington, D.C. As our nation grapples with unprecedented challenges—both individually and collectively—posed by the world-wide novel COVID-19 outbreak, it seems as though lightning has …
AACR Panel on Racism and Racial Inequalities in Cancer Research: Let It Not Be in Vain At the American Association for Cancer Research (AACR) Virtual Annual Meeting in June a special session hosted by AACR President Antoni Ribas, MD, PhD, FAACR, brought together a distinguished panel of leaders from academia, government, industry, and the patient advocacy community for a frank conversation on racism …
Legal Perspective: Clinical Trial Flexibilities Granted During COVID-19 During the COVID-19 Public Health Emergency, the U.S. Food and Drug Administration (FDA) granted some flexibilities for the conduct of clinical trials of medical products to help mitigate the impact of the pandemic on clinical studies and study participants. For perspective on what the landscape may look like post-pandemic, ACCC …
Patient Advocacy in Clinical Research Carla Strom, MLA, assistant director of operations in the Office of Cancer Health Equity at Wake Forest Baptist Comprehensive Cancer Center and a two-time young adult cancer survivor, discusses how her role as a patient advocate has evolved and why listening to the community voice early and often in research is vital.
 Read Full Article Carla Strom, MLA, is …
What Works Best in the Real World? Research studies on cancer prevention and screening provide evidence on efficacy of interventions. Clinical guidelines, USPSTF recommendations, and guidance from professional societies establish criteria for whom to screen and when. Implementation science research assesses how best to integrate these interventions into healthcare practice. Read Full Article Implementation …
Featured Clinical Research: The Impact of COVID-19 on Minority Communities In June, the New England Journal of Medicine published a study by Eboni G. Price-Haywood, MD, MPH, and colleagues, Hospitalization and Mortality among Black Patients and White Patients with Covid-19, that examined EHR patient data from Ochsner Health, an integrated healthcare delivery system, between March 1 and April 11, …
Closing Gaps – Building Trust in Clinical Trials for Our Communities Highlights from an FDA Oncology Center of Excellence panel discussion around improving clinical trial participation among historically under-represented patient populations. Experts suggest strategies like use of technology to help overcome implicit bias, hosting community events like host “Facts and Faith Friday,” and more. Read …
Sexual and Gender Minority Representation in Clinical Research: A Message from the President's Task Force With this issue, the ACCC Research Review looks at how community oncology can begin to address a significant gap in cancer research—knowledge and information on care for sexual and gender minority (SGM) patients with cancer. Recognition of the myriad inequities in care access, screening, …
Clinical Trials and AYAs: Listening and Learning By Krista Nelson, MSW, LCSW, OSW-C, BCD Krista Nelson is Program Manager Quality and Research, Cancer Support Services and Compassion, Providence Cancer Institute in Portland, Oregon. She defines her role as providing support for people and their families throughout the cancer continuum and sharing the expertise that she has learned from other patients …
Training for the Clinical Trials Workforce: A Message from the President's Task Force By Al B. Benson III, MD, FACP, FASCO This edition of the ACCC Research Review focuses on issues related to workforce training for cancer clinical research. Whether a cancer program is currently conducting clinical studies or is considering becoming a trial site, the bedrock on which all training rests is an understanding …
“All Power to the Patient: Achieving Cancer Health Equity” The FDA's Oncology Center of Excellence hosted a webcast on how the oncology community can improve cancer care for minority and underserved patients. Read five key takeaways for eliminating the systemic inequities that these patient populations face. Read Full Article In February, as part of Black History Month, the Food and Drug …
ACCC Has Strong Showing at 2022 ASCO Annual Meeting At ASCO 2022 ACCC showcased six abstracts on a wide range of topics from healthcare disparities and implicit bias to virtual learning and combating burnout. ICYMI, below is a brief review of these abstracts: Read Full Article In light of the significant disparities in clinical research, ACCC and ASCO joined forces to pilot an implicit bias …
Improving Access to Transgender Patients in Clinical Trials Each year between November 13-19, people and organizations around the country participate in Transgender Awareness Week to help raise the visibility about transgender people and address issues members of the community face. In recognition of this important event, issue of Research Review looks at ways to increase representation of transgender …
The Role of Research Infusion Nurses Oncology nursing is an inherently stressful job due to the emotional burdens and medical complexities of caring for patients with cancer. Since the outbreak of the pandemic, oncology nurses have only taken on additional responsibilities in patient care. Nursing distress, along with that of all healthcare providers, is at a record high these days, rising from about …
Profile: Society for Clinical Research Sites In 2012, Christine Pierre, a long-time nurse and industry leader in the clinical trial space, founded the Society for Clinical Research Sites (SCRS) after realizing that the research world lacked a unified voice for individual trial sites. This realization came in part from discussions with other industry leaders and in part from surveys identifying ongoing …
Krista Nelson, MSW, LCSW, OSW-C, FAOSW was named president of the Association of Community Cancer Centers (ACCC) on Friday, March 5, at the ACCC 47th Annual Meeting and Cancer Center Business Summit. Ms. Nelson will lead ACCC for the next year, as oncology professionals work to tackle critical issues in cancer care post-pandemic. Each year, ACCC invites its president to select a theme for their …
David R. Penberthy, MD, MBA, was named president of the Association of Community Cancer Centers (ACCC) on Friday, March 4, at the 48th Annual Meeting & Cancer Center Business Summit (AMCCBS), where oncology professionals gathered to discuss the convergence of business, policy, and technology in cancer care. Dr. Penberthy announced his 2022-23 President’s Theme, “Leveraging Technology to Transform …